About 200 reports

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Market Shares
  • Market Size

Chronic Neuropathic Pain KOL Survey Biomedtracker performed a ##-question survey of ## United States neurologists who currently treat patients with chronic neuropathic pain and prescribe opioids to at least some of their patients with chronic neuropathic

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Japan
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • United States
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Germany
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • United Kingdom
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Italy
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • France
  • Market Shares
  • Market Size

Chronic Pain Phase ## Clinical Trials, 2016 ##.

  • Chronic Disease
  • Chronic Pain
  • Spain
  • Market Shares
  • Market Size
  • Executive summary
  • Key takeaways

About the Intrathecal Pumps Market Intrathecal pumps are a category of analgesic infusion pumps that deliver medication into the individual's body for pain management. The intrathecal drug delivery pump is a method of giving medication directly to the spinal cord to stop pain signals from being perceived by the brain. These pumps...

  • Chronic Pain
  • Market Size
  • Flowonix Medical, Inc.
  • Medtronic, Inc.
  • Teleflex Incorporated
  • Chronic Pain
  • Types of Chronic Pain

Scope of the Report The report titled “The US Chronic Pain Therapy Market: Trends & Opportunities (2014-2019)” provides an in-depth analysis of the United States chronic pain therapy market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth and market share of the various drugs...

  • Chronic Pain
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Zogenix, Inc.
  • DRUGS UNDER DEVELOPMENT FOR SEVERE CHRONIC PAIN
  • APPROVED PHARMACOLOGICAL TREATMENT DRUGS FOR CHRONIC PAIN

Pain is defined as an unpleasant feeling brought on by a noxious stimuli or injury. The expression of pain can drive someone to stay away from harmful situations, defend injured tissues and avoid similar situations in future. Usually pain is classified as either acute or chronic, and can also be classified into mild, moderate and severe on...

  • Chronic Pain
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • 2.1 Preface
  • JIANGSU HENGRUI MEDICINE

About Neuropathy Pain Treatment Neuropathic pain is a complex, chronic pain condition that is accompanied by tissue injury. In neuropathic pain, the nerve fibers may be damaged, dysfunctional, or injured. These nerve fibers send incorrect signals to other pain centers. The impact of nerve fiber injury creates a change in nerve...

  • Chronic Pain
  • Depomed, Inc.
  • Eli Lilly & Co.
  • Endo International plc
  • Pfizer Inc.
  • Market drivers
  • Key vendor analysis

Although back support products offered by most vendors have low product differentiation, choosing back support for chronic pain requires detailed specifications as one back support cannot be used for all types of chronic pain in the middle, lower, upper b

  • Chronic Pain
  • Musculoskeletal Disorder
  • World
  • Demand
  • DeRoyal Industries, Inc.
  • Market segmentation by type

It targets TRPV-##, a receptor in specific afferent sensory neurons that become hyperactivated in diseases related to chronic and severe pain.

  • Chronic Pain
  • World
  • AstraZeneca PLC
  • Endo International plc
  • Pfizer Inc.

Chronic Pain, 2016 Acute pain versus chronic pain, by type of pain Table ##-##: Types of Physical Pain Suffered from Most in Past ## Months: Acute vs.

  • Chronic Disease
  • Chronic Pain
  • OTC
  • Pain Relief

This procedure reduces the pain and also increases the joint mobility.

  • Chronic Pain
  • World
  • Forecast
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Osteoarthritis Nutrition & Food Supplement Market: Revenue in USD million, Italy, 2015-2025
  • MARKET DYNAMICS

MARKET DYNAMICS DRIVERS INCREASING INCIDENCE OF OSTEOARTHRITIS Osteoarthritis is the most prevalent type of joint disease and also a leading cause of chronic pain and disability in the United States.

  • Chronic Pain
  • North America
  • United States
  • World
  • Koninklijke DSM N.V.

Neuropathic Pain Market and Forecast Analysis to 2024 TABLE OF CONTENTS ## TREATMENT: NEUROPATHIC PAIN (Published on ## March 2018) ## OVERVIEW ## EXECUTIVE SUMMARY ## PRIMARY RESEARCH METHODOLOGY ## DISEASE DEFINITION AND DIAGNOSIS ## PATIENT SEGMENTATION ## CURRENT TREATMENT OPTIONS

  • Chronic Disease
  • Chronic Pain
  • European Union
  • Japan
  • United States
  • 5.3 The US Chronic Pain Market Analysis
  • US CHRONIC PAIN MARKET 2014F-2019F (IN US$ BILLIONS)

Scope of the Report The report titled “Global Spinal Cord Stimulation Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of the global Spinal cord Stimulation market (including medication, surgeries and therapies) with detailed analysis of market sizing and growth. It also assesses the key opportunities...

  • Chronic Pain
  • United States
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Medtronic, Inc.

Opioids and Chronic Neuropathic Pain Management KOL Interview Biomedtracker interviewed a neurologist based in the United States who currently treats over ## patients with chronic neuropathic pain per year to determine his current treatment practices for indications incl

  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States
  • LATEST CLINICAL TRIALS NEWS ON CHRONIC PAIN
  • CHRONIC PAIN THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2017*

Chronic Pain Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Pain Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pain. Report includes an...

  • Chronic Pain
  • Clinical Trial
  • Hospital
  • Opioid
  • Pain Therapeutics

Abuse-Deterrent Opioids Survey KOL Interview Biomedtracker performed a ##-question survey of ## United States primary care physicians who currently treat patients with chronic pain and prescribe opioids to at least some of their patients with chronic pain to gauge

  • Ambulatory Care
  • Chronic Disease
  • Chronic Pain
  • Pathology
  • United States
  • CHRONIC BACK PAIN THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2017*
  • Clinical Trial profile. 9 Trial Title

Chronic Back Pain Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Chronic Back Pain Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Back Pain....

  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative
  • Chronic Pain - Dormant Projects
  • Chronic Pain - Discontinued Products

Chronic Pain - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete with analysis by stage of...

  • Chronic Pain
  • Research And Development
  • United States
  • Company
  • Company Operations
  • Chronic neuropathic pain is caused by injury or another disease. Some common causes may include
  • INTRODUCTION

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Neuropathic Pain in 15 Major Markets Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other conditions or diseases such as diabetes or herpes zoster infection, and is often accompanied...

  • Chronic Disease
  • Chronic Pain
  • Pathology

The condition has different symptoms such as joint pain, swelling, and stiffness, which are generally accompanied by chronic pain and inability to perform daily activities.

  • Arthritis
  • Chronic Pain
  • United States
  • Forecast
  • Market Size
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY
  • PRODUCT PROFILE - CYMBALTA

PharmaPoint: Fibromyalgia - Global Drug Forecast and Market Analysis to 2023 Summary The fibromyalgia market is relatively new and not yet established. Three drugs currently dominate the sales across the 7MM and form the core treatment options; Lyrica, Cymbalta and Savella are all approved in the US while only the former...

  • Chronic Pain
  • Actavis plc
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Forest Laboratories, Inc.
  • 17. Market Trends
  • 06. Introduction

Cymbalta is also approved for the treatment of generalized anxiety disorder, major depressive disorder, diabetic peripheral neuropathic pain, and chronic musculoskeletal pain.

  • Chronic Pain
  • World
  • Actavis plc
  • Eli Lilly & Co.
  • Pfizer Inc.